We're thrilled to announce that our study, describing the breakthrough results of the PERSONAL-CovidPB clinical trial, has been published in @JAHA_AHA. Read the full press release to learn how we're using these data:

We have been selected to join #NVIDIAinception, an accelerator program led by world-leading AI Computing company, @nvidia, designed to nurture startups and early-stage companies revolutionizing industries with technological advancements. Read more:

RT @EBRmagazine: Hakim Yadi at @Closed_Loop_med: what role can the industry play in treating one of the biggest #silentkillers?.Read here:….

.@AmDiabetesAssn returns for its 84th Annual Scientific Session on June 21st! #ADA2024.Arrange a meeting with @hakim_yadi to discuss how we are facilitating personalized disease management to improve the effectiveness of medicines, such as GLP-1s:

In this interview with @EBRmagazine our CEO @hakim_yadi shared his insights on the global impact of mismanaged #hypertension, current healthcare limitations, and how novel technology applications and personalized dosing can revolutionize treatment, p.39-41

In this @INVIVOnow podcast, our CEO @Hakim_Yadi discussed how Closed Loop Medicine’s approach in pairing software as a medical device with advanced analytics and drugs can enhance personalized care across multiple therapeutic areas. Listen here:

Today we welcome Paul Johnson to the Board as a Non-Executive Director. With extensive experience in digital #healthcare and e-commerce, Paul joins to support the commercialization strategy for our integrated #precision care solutions:

Tomorrow is #WorldHypertensionDay. Together with Pharmanovia, we are excited to announce the first patient recruitment and of a study investigating personalized dose management of an anti-hypertensive in improving blood pressure control. COR2024SM00107.Date Prepared: May 2024

The #PrixGalien UK Forum returns on May 30, celebrating excellence in medical research. Attending as a panelist is our CEO, @Hakim_Yadi for the session titled, “Introducing new technologies: optimising pathways to improve population health.”

In case you missed it, our CEO @Hakim_Yadi sat with @BioCentury to discuss how applying real-time PK/PD monitoring to personalize the dosing of #GLP1s can improve patient outcomes. Read the full article at BioCentury: #Obesity #PrecisionCare #TechBio

Curious about how #translationalscience can bridge the gap between basic research and clinical applications? Join our CEO @hakim_yadi at @lifearc1’s Translational Science Summit for an insightful day of exploration and discovery. For more info visit:

Watch this video abstract outlining our clinical trial findings in @JAHA_AHA, which validate the use of our proprietary technology for the identification of a personalized dose regimen for the management of #hypertension:

Few weeks left until #BioTrinity 2024, @OBN_UK’s premier event! Hear from CEO @Hakim_Yadi on April 24 at the Platforms For Drug Discovery & Development Spotlight. Discover how Closed Loop Medicine delivers #precisioncare:

Have you listened to @BioCentury’s This Week podcast, where @jeff_cranmer and @StephenPHansen discuss our precision care approach for enhancing the tolerance and efficacy of obesity treatments without limiting market size. Listen to the episode here:

RT @FrontiersHealth: 🆕@closed_loop_med and Teva UK forge strategic partnership to revolutionize Personalized Medicines .

RT @fwhealthtech: Less generic, more specific? Teva taps Closed Loop Medicine for precision medicine .@tevapharm .@….

We’re excited to announce a strategic partnership with @Teva_UK, a collaboration aimed at advancing the development of personalized medicines. Read the full press release here: #PrecisionCare #DigitalHealth #TechBio #ChronicDisease

RT @BioCentury: “What we’re saying is there’s an opportunity to use real-time, real-world PK/PD to personalize dosing of products like GLP-….

Today is #InternationalWomensDay. #WomensHealth has been neglected in clinical trials limiting treatment success. Personalized dose optimization can help ensure optimal outcomes for each individual. Learn more about our mission to deliver #precisioncare:

👉Can we apply precision care to obesity without limiting market size? Our CEO, @hakim_yadi, shared his thoughts in an interview with @BioCentury. Read the full article here: #Obesity #PrecisionCare #HealthTech #DigitalHealth #TechBio

RT @JAHA_AHA: A personalized app enabling blood pressure and side-effect recording allowed precision-dose titration of amlodipine and impro….